Healthcare & Life Sciences
Requiole
About
Requiole is developing first-in-class pan-cancer synthetic drug conjugates for solid tumors.
Explore Requiole's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.